Advancements in understanding anaphylaxis: From triggers to therapeutic strategies

Le résumé fourni par la source

Anaphylaxis is a complex and dynamic condition, marked by a heterogeneity of triggers, pathophysiological pathways, and clinical presentations. Although IgE-mediated immune responses are the predominant drivers of anaphylaxis, non-IgE-mediated mechanisms, including complement activation, engagement of the contact system, and IgG-mediated processes, also significantly contribute to its pathogenesis. Furthermore, non-immune-mediated pathways, such as MRGPRX2 receptor activation, play a pivotal role in the initiation of anaphylactic reactions. The diagnosis of anaphylaxis predominantly hinges on the recognition of clinical manifestations. Nevertheless, biomarkers like tryptase and CPA3, as well as genetic markers, serve as critical adjuncts in confirming the diagnosis, evaluating the severity of the reaction, and forecasting the prognosis. The accurate identification and avoidance of allergens are fundamental strategies for preventing recurrent anaphylactic episodes. Provision of epinephrine auto-injectors empower patients with effective tools for self-management. Future research endeavors should concentrate on deepening the understanding of the multifaceted pathophysiology of anaphylaxis, advancing the development of precise diagnostic modalities, and refining therapeutic strategies. Enhancing patient education and management protocols is also essential. These collective efforts are aimed at diminishing the incidence and mortality associated with anaphylaxis, thereby enhancing the quality of life for affected individuals.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.